1492 Capital Management LLC Crispr Therapeutics Ag Transaction History

1492 Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $183 - $251	-3 Reduced 0.02%	12,005 $785,000
Q2 2022 Aug 10, 2022	BUY	$43.23 - $73.83 $519,105 - $886,550	12,008 New	12,008 $730,000
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $648,753 - $1.03 Million	-9,256 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $7,493 - $10,651	-68 Reduced 0.73%	9,256 $1.04 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $597,376 - $959,036	5,924 Added 174.24%	9,324 $1.51 Million
Q1 2021 May 12, 2021	SELL	$110.72 - $210.04 $8,857 - $16,803	-80 Reduced 2.3%	3,400 $414,000
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $462,325 - $1.01 Million	-5,803 Reduced 62.51%	3,480 $533,000
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $57,383 - $73,567	731 Added 8.55%	9,283 $776,000
Q2 2020 Aug 13, 2020	SELL	$38.5 - $76.05 $1,655 - $3,270	-43 Reduced 0.5%	8,552 $628,000
Q1 2020 May 12, 2020	SELL	$33.68 - $62.53 $6,533 - $12,130	-194 Reduced 2.21%	8,595 $365,000
Q4 2019 Feb 06, 2020	BUY	$36.68 - $73.13 $322,380 - $642,739	8,789 New	8,789 $535,000
Q1 2019 May 14, 2019	SELL	$28.02 - $40.87 $438,036 - $638,920	-15,633 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $48,460 - $90,268	-2,132 Reduced 12.0%	15,633 $447,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $787,877 - $1.17 Million	17,765 New	17,765 $788,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.